Scopus WoS Q2
SCI Hakemli
Design, synthesis, anticancer activity, bioimaging, and molecular docking of novel fluorescent isatin derivatives
INVESTIGATIONAL NEW DRUGS · 2026
"Isatin-naphthalimide conjugates"
"Fluorescent theranostics"
"VEGFR2 docking"
"Molecular docking"
"Breast cancer cells"
"Subcellular targeting"
"Apoptosis induction"